[Evolution of hematological parameters in a group of children with human immunodeficiency virus infection - HIV 1]

E B Silva1, M T Silva, M M Vilela

  • 1Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil.

Jornal De Pediatria
|December 20, 2003
PubMed

Insights

Anemia and lymphopenia are linked to disease progression in children with HIV-1 infection. Hematological abnormalities may result from impaired cell death and hematopoiesis control in these patients.

Area of Science:

  • Pediatrics
  • Hematology
  • Infectious Diseases

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) infection presents unique challenges in pediatric populations.
  • Understanding the clinical and hematological evolution is crucial for managing pediatric HIV-1.
  • Antiretroviral therapy is standard care but does not eliminate all complications.

Purpose of the Study:

  • To analyze the clinical and hematological changes over time in children infected with HIV-1.
  • To identify associations between hematological findings and disease progression.

Main Methods:

  • Longitudinal descriptive study of 37 children with HIV-1 infection.
  • Utilized CDC criteria (1994) for classification.
  • Performed complete blood counts, ferritin, serum iron, TIBC, and direct Coombs tests.

Main Results:

  • Anemia (hypochromic, microcytic) was present in 100% of infants up to 12 months.
  • Anemia correlated significantly with clinical (p=0.031) and immunological (p=0.0027) progression, and lymphopenia (p=0.033).
  • Weight/height reduction occurred in 23.5-45%; 13.2% of patients died during follow-up.

Conclusions:

  • Anemia and lymphopenia are associated with HIV-1 disease progression in children.
  • Hematological abnormalities likely stem from dysregulation of cell death and hematopoiesis.
  • Approximately 10% of anemia cases may be attributable to chronic disease.